GeneDx Holdings (WGS) Income towards Parent Company (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly Income towards Parent Company of -$63.3 million for Q1 2026, down 869.81% year-over-year from $8.2 million in Q1 2025, and down 258.42% quarter-over-quarter from -$17.7 million in Q4 2025.
GeneDx Holdings (WGS) Income towards Parent Company (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Income towards Parent Company for 7 consecutive years, with -$63.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Income towards Parent Company fell 869.81% year-over-year to -$63.3 million; the TTM figure through Mar 2026 stood at -$77.8 million (down 101.74% YoY), while the FY2025 annual figure was -$21.0 million, up 59.8% from the prior year.
- Income towards Parent Company eased to -$63.3 million in Q1 2026 per WGS's latest filing, from -$17.7 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $10.8 million in Q2 2025 and bottomed at -$308.7 million in Q4 2022.
- Historically, Income towards Parent Company has averaged -$50.7 million across 5 years, with a median of -$29.2 million in 2024.
- Annual changes were most pronounced in 2025 — Income towards Parent Company soared 137.06% — and 2026, when it tumbled 869.81%.
- GeneDx Holdings' Income towards Parent Company stood at -$308.7 million in 2022, then soared by 91.66% to -$25.8 million in 2023, then jumped by 121.19% to $5.5 million in 2024, then tumbled by 423.73% to -$17.7 million in 2025, then sank by 258.42% to -$63.3 million in 2026.
- Business Quant data shows WGS's Income towards Parent Company at -$63.3 million in Q1 2026, -$17.7 million in Q4 2025, and -$7.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | GeneDx Holdings | 2.65 Bn | 2.52 Bn | 78.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.74 Mn |
| Mar 31, 2026 | -63.32 Mn |
| Dec 31, 2025 | -17.67 Mn |
| Sep 30, 2025 | -7.64 Mn |
| Jun 30, 2025 | 10.81 Mn |
| Mar 31, 2025 | -6.53 Mn |
| Dec 31, 2024 | 5.44 Mn |
| Sep 30, 2024 | -8.31 Mn |
| Jun 30, 2024 | -29.16 Mn |
| Mar 31, 2024 | -20.22 Mn |
| Dec 31, 2023 | -25.77 Mn |
| Sep 30, 2023 | -42.29 Mn |
| Jun 30, 2023 | -46.72 Mn |
| Mar 31, 2023 | -60.99 Mn |
| Dec 31, 2022 | -308.71 Mn |
| Sep 30, 2022 | -77.58 Mn |
| Jun 30, 2022 | -85.74 Mn |
| Mar 31, 2022 | -76.90 Mn |
| Dec 31, 2021 | -40.19 Mn |
| Sep 30, 2021 | 32.73 Mn |